Profile change history

What changed for Vosoritide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Vosoritide identity.

62Total events
58Record additions
4Version changes
6Cited source years

Before and after

Preserved version changes

Record updated

A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.

PubMed revised the bibliographic metadata of PMID 42713641, with a metadata revision date of 2026-11-09. This version reports that observation; the earlier retained observation remains available as version 1.

PeptideScanner change date
November 16, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata

Summary

Before
PubMed lists PMID 42713641 in NEJM evidence as Journal Article, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
After
PubMed lists PMID 42713641 in NEJM evidence as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Cited source date

Before
2026-09-09
After
2026-11-09

Source observed date

Before
2026-09-09
After
2026-11-16

Cited source records

Before
pubmed-observation-pmid-42713641-2026-09-09-3296b303c913
After
pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2

Headline citations

Before
pubmed-observation-pmid-42713641-2026-09-09-3296b303c913
After
pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2

Summary citations

Before
pubmed-observation-pmid-42713641-2026-09-09-3296b303c913
After
pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2

Attributable context

Before
1. PubMed lists PMID 42713641 in NEJM evidence as Journal Article, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. [sources: pubmed-observation-pmid-42713641-2026-09-09-3296b303c913] 2. This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. [sources: pubmed-observation-pmid-42713641-2026-09-09-3296b303c913]
After
1. PubMed lists PMID 42713641 in NEJM evidence as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. [sources: pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2] 2. This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. [sources: pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2]

Source snapshot commitment

Before
362b66e72d321a02130be7ccc7c20cd080741bd1e97c36106f63d64584349bd0
After
2fa248719f85b34615d923fa046cfed2db32537d3bf8c781c7d6a6846f844e57
Record updated

ClinicalTrials.gov record NCT06455059

ClinicalTrials.gov posted a newer version of NCT06455059, with a registry update date of 2026-11-12. This version reports that observation; the earlier retained observation remains available as version 1.

PeptideScanner change date
November 15, 2026
Cited source date
November 12, 2026
Evidence lane
Clinical trials

Summary

Before
PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-20, and PeptideScanner's reviewed identity mapping was vosoritide.
After
PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was vosoritide.

Cited source date

Before
2026-01-20
After
2026-11-12

Source observed date

Before
2026-07-30
After
2026-11-15

Cited source records

Before
ctg-observation-nct06455059-2026-01-20-bc7bbe888685
After
ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2

Headline citations

Before
ctg-observation-nct06455059-2026-01-20-bc7bbe888685
After
ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2

Summary citations

Before
ctg-observation-nct06455059-2026-01-20-bc7bbe888685
After
ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2

Attributable context

Before
1. PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-20, and PeptideScanner's reviewed identity mapping was vosoritide. [sources: ctg-observation-nct06455059-2026-01-20-bc7bbe888685] 2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct06455059-2026-01-20-bc7bbe888685]
After
1. PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was vosoritide. [sources: ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2] 2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2]

Source snapshot commitment

Before
c1a134540208b7c8559cbc8ed3b095213b97e583eb44ff6fd381e3a4f1d8772a
After
ff91dcd0672ce96a0e8ce77dd07de1a38c73643f2e2734fc60c686dbd64fca9c
Profile status changed

Vosoritide profile

We added a plain-language reader guide with cited answers, re-checked the Voxzogo label, and added the Drugs@FDA approval record.

PeptideScanner change date
November 14, 2026
Evidence lane
Profile

Status

Before
U.S. label record
After
FDA-approved as Voxzogo under accelerated approval for achondroplasia

Profile summary

Before
A C-type natriuretic peptide analogue. This profile cites a U.S. label record.
After
A C-type natriuretic peptide analogue approved by FDA as Voxzogo, under accelerated approval, to increase linear growth in children with achondroplasia whose growth plates are open.

Evidence note

Before
The cited DailyMed label identifies Vosoritide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.
After
A 52-week randomized, placebo-controlled trial in 121 children described in the label found faster annual growth than with placebo. Continued approval may depend on confirmatory trials of clinical benefit.

Cited source records

Before
dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16
After
dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16, fda-drugs-nda214938-2021-11-19-6bf5863742a4

Named organizations

Before
U.S. National Library of Medicine [sources: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16]
After
U.S. National Library of Medicine [sources: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16]; U.S. Food and Drug Administration [sources: fda-drugs-nda214938-2021-11-19-6bf5863742a4]

Claim citations

Before
name: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; aliases: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; category: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; status: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; summary: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; evidenceNote: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16
After
name: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; aliases: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; category: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; status: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16, fda-drugs-nda214938-2021-11-19-6bf5863742a4; summary: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16, fda-drugs-nda214938-2021-11-19-6bf5863742a4; evidenceNote: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16
Profile updated

Vosoritide profile

We rewrote the profile summary to describe the cited public record more directly. The cited sources and status did not change.

PeptideScanner change date
July 27, 2026
Evidence lane
Profile

Profile summary

Before
A C-type natriuretic peptide analogue represented in current U.S. drug-label records.
After
A C-type natriuretic peptide analogue. This profile cites a U.S. label record.

Collection chronology

Evidence added to PeptideScanner

Browse all 58 connected records →

Showing the latest 58 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 14, 2026.

Record added

Early closure of cranial base synchondroses in infants with Vosoritide-treated achondroplasia.

PubMed lists PMID 42825290 in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology as Journal Article, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 14, 2026
Cited source date
October 3, 2026
Evidence lane
Literature metadata
Record added

Vosoritide therapy in Brazil: Consensus on the Diagnosis, Monitoring, and Management of Achondroplasia.

PubMed lists PMID 42983735 in Orphanet journal of rare diseases as Journal Article, Consensus Statement, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-08-06 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 14, 2026
Cited source date
November 6, 2026
Evidence lane
Literature metadata
Record added

ClinicalTrials.gov record NCT02055157

PeptideScanner retained ClinicalTrials.gov record NCT02055157 at 2026-07-30T20:07:13.490Z. Its registry update date was 2021-01-15, and PeptideScanner's reviewed identity mapping was vosoritide.

PeptideScanner change date
September 9, 2026
Cited source date
January 15, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03989947

PeptideScanner retained ClinicalTrials.gov record NCT03989947 at 2026-07-30T16:22:22.327Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

PeptideScanner change date
September 9, 2026
Cited source date
March 13, 2026
Evidence lane
Clinical trials
Record added

A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.

PubMed lists PMID 42713641 in NEJM evidence as Journal Article, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
September 9, 2026
Cited source date
September 9, 2026
Evidence lane
Literature metadata
Record added

Vosoritide DailyMed SPL version 10

DailyMed lists Structured Product Labeling version 10 for the reviewed Vosoritide label family with a published date of 2023-11-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
November 15, 2023
Evidence lane
Regulatory
Record added

Vosoritide DailyMed SPL version 11

DailyMed lists Structured Product Labeling version 11 for the reviewed Vosoritide label family with a published date of 2024-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
April 12, 2024
Evidence lane
Regulatory
Record added

Vosoritide DailyMed SPL version 12

DailyMed lists Structured Product Labeling version 12 for the reviewed Vosoritide label family with a published date of 2024-04-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
April 15, 2024
Evidence lane
Regulatory
Record added

Vosoritide DailyMed SPL version 14

DailyMed lists Structured Product Labeling version 14 for the reviewed Vosoritide label family with a published date of 2024-11-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
November 13, 2024
Evidence lane
Regulatory
Record added

Vosoritide DailyMed SPL version 15

DailyMed lists Structured Product Labeling version 15 for the reviewed Vosoritide label family with a published date of 2024-12-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
December 20, 2024
Evidence lane
Regulatory
Record added

Vosoritide DailyMed SPL version 16

DailyMed lists Structured Product Labeling version 16 for the reviewed Vosoritide label family with a published date of 2025-11-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
November 26, 2025
Evidence lane
Regulatory
Record added

Vosoritide DailyMed SPL version 8

DailyMed lists Structured Product Labeling version 8 for the reviewed Vosoritide label family with a published date of 2021-12-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
December 3, 2021
Evidence lane
Regulatory
Record added

Federal Register notice 2022-19155

The Federal Register published notice 2022-19155, attributed to FDA and its parent HHS department, on 2022-09-06. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide.

PeptideScanner change date
August 21, 2026
Cited source date
September 6, 2022
Evidence lane
Regulatory
Record added

Federal Register notice 2023-03364

The Federal Register published notice 2023-03364, attributed to FDA and its parent HHS department, on 2023-02-17. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Afamelanotide, Glucagon, Leuprolide and Vosoritide.

PeptideScanner change date
August 21, 2026
Cited source date
February 17, 2023
Evidence lane
Regulatory
Record added

Federal Register notice 2024-04479

The Federal Register published notice 2024-04479, attributed to FDA and its parent HHS department, on 2024-03-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VOXZOGO,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide.

PeptideScanner change date
August 21, 2026
Cited source date
March 4, 2024
Evidence lane
Regulatory
Record added

Federal Register notice 2025-22131

The Federal Register published notice 2025-22131, attributed to FDA and its parent HHS department, on 2025-12-05. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.

PeptideScanner change date
August 21, 2026
Cited source date
December 5, 2025
Evidence lane
Regulatory
Record added

Federal Register notice 2026-15285

The Federal Register published notice 2026-15285, attributed to FDA and its parent HHS department, on 2026-07-29. Its official title is “Product-Specific Guidances; Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.

PeptideScanner change date
August 21, 2026
Cited source date
July 29, 2026
Evidence lane
Regulatory
Record added

ClinicalTrials.gov record NCT02724228

PeptideScanner retained ClinicalTrials.gov record NCT02724228 at 2026-07-30T16:22:22.336Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

PeptideScanner change date
August 14, 2026
Cited source date
March 13, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07126262

PeptideScanner retained ClinicalTrials.gov record NCT07126262 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was vosoritide.

PeptideScanner change date
August 14, 2026
Cited source date
March 31, 2026
Evidence lane
Clinical trials
Record added

Vosoritide: First Approval.

PubMed lists PMID 34694597 in Drugs as Journal Article, Review, with publication-date metadata of 2021-11 (month precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
February 14, 2022
Evidence lane
Literature metadata
Record added

Vosoritide.

PubMed lists PMID 35180295 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2022-03-07 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
March 16, 2022
Evidence lane
Literature metadata
Record added

Vosoritide treatment for children with hypochondroplasia: a phase 2 trial.

PubMed lists PMID 38813446 in EClinicalMedicine as Journal Article, with publication-date metadata of 2024-04-11 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
May 31, 2024
Evidence lane
Literature metadata
Record added

Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia.

PubMed lists PMID 39062238 in Children (Basel, Switzerland) as Journal Article, with publication-date metadata of 2024-06-28 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 29, 2024
Evidence lane
Literature metadata
Record added

Vosoritide therapy in children with achondroplasia under 5 years of age.

PubMed lists PMID 39399714 in Translational pediatrics as Editorial, Comment, with publication-date metadata of 2024-09-11 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
October 15, 2024
Evidence lane
Literature metadata
Record added

Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence.

PubMed lists PMID 40821249 in Cureus as Journal Article, Review, with publication-date metadata of 2025-07-15 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
September 14, 2025
Evidence lane
Literature metadata
Record added

Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report.

PubMed lists PMID 41078071 in Hormone research in paediatrics as Case Reports, Journal Article, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2025
Evidence lane
Literature metadata
Record added

Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide.

PubMed lists PMID 41340868 in Genetics in medicine open as Journal Article, with publication-date metadata of 2025-10-13 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
December 6, 2025
Evidence lane
Literature metadata
Record added

PubMed record PMID 38649657

PeptideScanner retained PubMed bibliographic metadata for PMID 38649657 at 2026-08-10T18:13:32.355Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-04-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 2, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 39289684

PeptideScanner retained PubMed bibliographic metadata for PMID 39289684 at 2026-07-30T16:20:39.015Z. PubMed recorded a metadata revision date of 2026-05-19 and an Entrez history date of 2024-09-17. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
May 19, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 39305160

PeptideScanner retained PubMed bibliographic metadata for PMID 39305160 at 2026-07-30T16:14:08.845Z. PubMed recorded a metadata revision date of 2026-06-30 and an Entrez history date of 2024-09-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
June 30, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 39740666

PeptideScanner retained PubMed bibliographic metadata for PMID 39740666 at 2026-07-30T16:14:08.917Z. PubMed recorded a metadata revision date of 2026-06-07 and an Entrez history date of 2024-12-31. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
June 7, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 39864410

PeptideScanner retained PubMed bibliographic metadata for PMID 39864410 at 2026-07-30T16:14:08.934Z. PubMed recorded a metadata revision date of 2026-06-03 and an Entrez history date of 2025-01-26. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
June 3, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 40099812

PeptideScanner retained PubMed bibliographic metadata for PMID 40099812 at 2026-07-30T16:14:10.937Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-03-18. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
June 9, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41157964

PeptideScanner retained PubMed bibliographic metadata for PMID 41157964 at 2026-07-30T16:22:16.190Z. PubMed recorded a metadata revision date of 2026-04-21 and an Entrez history date of 2025-10-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
April 21, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41610120

PeptideScanner retained PubMed bibliographic metadata for PMID 41610120 at 2026-07-30T16:11:44.897Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 1, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41615893

PeptideScanner retained PubMed bibliographic metadata for PMID 41615893 at 2026-07-30T16:22:18.348Z. PubMed recorded a metadata revision date of 2026-04-04 and an Entrez history date of 2026-01-30. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
April 4, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41621839

PeptideScanner retained PubMed bibliographic metadata for PMID 41621839 at 2026-08-10T18:13:40.584Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-02-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 6, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41762856

PeptideScanner retained PubMed bibliographic metadata for PMID 41762856 at 2026-08-10T18:13:42.759Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-02-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 9, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41783511

PeptideScanner retained PubMed bibliographic metadata for PMID 41783511 at 2026-07-30T16:23:41.272Z. PubMed recorded a metadata revision date of 2026-03-05 and an Entrez history date of 2026-03-05. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
March 5, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41967490

PeptideScanner retained PubMed bibliographic metadata for PMID 41967490 at 2026-07-30T16:22:18.495Z. PubMed recorded a metadata revision date of 2026-04-12 and an Entrez history date of 2026-04-12. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
April 12, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42001280

PeptideScanner retained PubMed bibliographic metadata for PMID 42001280 at 2026-08-10T18:13:48.756Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-04-19. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 17, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42043535

PeptideScanner retained PubMed bibliographic metadata for PMID 42043535 at 2026-07-30T16:20:43.712Z. PubMed recorded a metadata revision date of 2026-05-22 and an Entrez history date of 2026-04-27. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
May 22, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42238253

PeptideScanner retained PubMed bibliographic metadata for PMID 42238253 at 2026-07-30T16:14:18.068Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
June 4, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41810698

PeptideScanner retained PubMed bibliographic metadata for PMID 41810698 at 2026-08-10T18:13:44.816Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
July 23, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42479670

PeptideScanner retained PubMed bibliographic metadata for PMID 42479670 at 2026-08-10T18:13:56.698Z. PubMed recorded a metadata revision date of 2026-07-21 and an Entrez history date of 2026-07-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
July 21, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42495828

PeptideScanner retained PubMed bibliographic metadata for PMID 42495828 at 2026-08-10T18:13:56.737Z. PubMed recorded a metadata revision date of 2026-07-24 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
July 24, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42518139

PeptideScanner retained PubMed bibliographic metadata for PMID 42518139 at 2026-08-10T18:13:56.769Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
July 29, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41424367

PeptideScanner retained PubMed bibliographic metadata for PMID 41424367 at 2026-08-10T10:49:08.725Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 10, 2026
Cited source date
July 30, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41764752

PeptideScanner retained PubMed bibliographic metadata for PMID 41764752 at 2026-08-10T10:49:08.778Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-03-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 10, 2026
Cited source date
July 31, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42026358

PeptideScanner retained PubMed bibliographic metadata for PMID 42026358 at 2026-08-10T10:49:08.854Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-04-23. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 10, 2026
Cited source date
August 6, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42519733

PeptideScanner retained PubMed bibliographic metadata for PMID 42519733 at 2026-08-10T18:13:56.777Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 10, 2026
Cited source date
July 29, 2026
Evidence lane
Literature metadata
Record added

ClinicalTrials.gov record NCT05845749

PeptideScanner retained ClinicalTrials.gov record NCT05845749 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was vosoritide.

PeptideScanner change date
August 9, 2026
Cited source date
March 10, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05849389

PeptideScanner retained ClinicalTrials.gov record NCT05849389 at 2026-07-30T18:43:56.187Z. Its registry update date was 2024-06-24, and PeptideScanner's reviewed identity mapping was vosoritide.

PeptideScanner change date
August 9, 2026
Cited source date
June 24, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06455059

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-20, and PeptideScanner's reviewed identity mapping was vosoritide.

PeptideScanner change date
August 9, 2026
Cited source date
January 20, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07073014

PeptideScanner retained ClinicalTrials.gov record NCT07073014 at 2026-07-30T18:24:37.179Z. Its registry update date was 2025-07-18, and PeptideScanner's reviewed identity mapping was vosoritide.

PeptideScanner change date
August 9, 2026
Cited source date
July 18, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04219007

PeptideScanner retained ClinicalTrials.gov record NCT04219007 at 2026-07-30T16:22:22.347Z. Its registry update date was 2026-03-18, and PeptideScanner's reviewed identity mapping was vosoritide.

PeptideScanner change date
August 8, 2026
Cited source date
March 18, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04554940

PeptideScanner retained ClinicalTrials.gov record NCT04554940 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

PeptideScanner change date
August 8, 2026
Cited source date
March 13, 2026
Evidence lane
Clinical trials